In real-world data, GLP-1RAs differ in clinical indications, uptake over time, adherence rate, typical treatment duration, dose escalation, and patient selection, all of which can introduce residual confounding and channeling bias ( Notably, the observed reductions in the odds of substance use disorders, including a 74% decrease in the odds of AUD, a 69% reduction for OUD, a 68% reduction for NUD, and a 75% reduction for CUD, among GLP-1 RA users were consistent with emerging preclinical and clinical studies showing that GLP-1 RA modulates reward pathways in the brain to reduce SUD ( 4.1 Strengths and limitations of the study This study has several notable strengths
a) Common Side Effects Nausea Vomiting Diarrhea Constipation Stomach discomfort or bloating These side effects are usually mild or moderate and often get better as your body gets used to the medicine
However, it's essential to approach supplementation with caution, ensuring you follow recommended doses and consult with a healthcare professional if needed
The absorption variability also means dose adjustments are harder to interpret
Hunger may be more noticeable, especially early on, but semaglutide and other GLP-1 medications can make this approach surprisingly doable
Adjust Your Timing: If you find that you feel sleepy shortly after taking it, try moving your dose to the evening